News Item

May 17, 2016
The EMA issued a positive opinion on the orphan drug designation for VS-01 for the treatment of acute liver failure.

17 May 2016: the Committee for Orphan Medicinal Products (COMP), in light of the overall data submitted and the discussion within the Committee, issued a positive opinion on orphan medicinal product designation for VS-01 for the treatment of acute liver failure.